1 | 6X4A |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-chloro-7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-8-methyl-2-naphthonitrile |
7AY |
|
0.97 |
SHOW |
2 | 5TW3 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-7-fluoronaphthalene-2-carbonitrile |
7N1 |
|
0.95 |
SHOW |
3 | 6X4C |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-5,8-dimethylnaphthalene-2-carbonitrile |
UNS |
|
0.9 |
SHOW |
4 | 6X4D |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-(cyclopropylmethyl)-7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-8-methylnaphthalene-2-carbonitrile |
UO4 |
|
0.88 |
SHOW |
5 | 6X4E |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
methyl (6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)acetate |
UMV |
|
0.87 |
SHOW |
6 | 6DTW |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
0.84 |
SHOW |
7 | 6X4F |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
methyl (6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)acetate |
UMV |
|
0.83 |
SHOW |
8 | 6DTX |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
0.82 |
SHOW |
9 | 6X47 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
0.8 |
SHOW |
10 | 6X49 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
0.77 |
SHOW |
11 | 1S1V |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL |
TNK |
|
0.77 |
SHOW |
12 | 4KV8 |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
11-ethyl-5-methyl-8-[2-(1-oxidanylquinolin-4-yl)oxyethyl]dipyrido[3,2-[1,4]diazepin-6-one |
1WT |
|
0.77 |
SHOW |
13 | 1IKX |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE |
PNU |
|
0.7 |
SHOW |
14 | 6UL5 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl)amino]-2-fluorobenzonitrile |
QAG |
|
0.68 |
SHOW |
15 | 1S6Q |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE |
TPB |
|
0.67 |
SHOW |
16 | 1S9E |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE |
ADB |
|
0.63 |
SHOW |
17 | 3MEG |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile |
T27 |
|
0.63 |
SHOW |
18 | 6NW4 |
Indole-3-glycerol phosphate synthase | Saccharolobus solfataricus |
Q06121 (TRPC_SACS2) |
6-NITROBENZOTRIAZOLE |
6NT |
|
0.48 |
SHOW |
19 | 2YK1 |
Fab fragment heavy chain | Homo sapiens |
- |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.45 |
SHOW |
20 | 2PCP |
Monoclonal 6B5 Fab | Mus musculus |
- |
1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE |
1PC |
|
0.43 |
SHOW |
21 | 5CEH |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
7-oxo-5-phenyl-6-(propan-2-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile |
50P |
|
0.43 |
SHOW |
22 | 2ZJU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine |
IM4 |
|
0.43 |
SHOW |
23 | 4KYS |
Thiamine pyridinylase I | Clostridium botulinum A str. ATCC 19397 |
- |
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM |
VIB |
|
0.42 |
SHOW |
24 | 6D59 |
GTPase Hras | Homo sapiens |
P01112 (RASH_HUMAN) |
6-chloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-2-(piperazin-1-yl)-1H-benzimidazole |
FVJ |
|
0.41 |
SHOW |
25 | 1RUM |
Igk protein | Mus musculus |
Q58EU8 (Q58EU8_MOUSE) |
BENZOIC ACID |
BEZ |
|
0.41 |
SHOW |
26 | 1RUA |
Ig gamma-2A chain C region, membrane-bound form | Mus musculus |
P01865 (GCAM_MOUSE) |
BENZOIC ACID |
BEZ |
|
0.41 |
SHOW |
27 | 6VM2 |
Glycine receptor subunit alphaZ1 | Danio rerio |
O93430 (GLRA1_DANRE) |
GLYCINE |
GLY |
|
0.41 |
SHOW |
28 | 4LC5 |
Cytidine and deoxycytidylate deaminase zinc-binding region | Nitrosomonas europaea |
Q82Y41 (Q82Y41_NITEU) |
9-METHYLGUANINE |
9MG |
|
0.41 |
SHOW |
29 | 1RAO |
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | Escherichia coli |
P26281 (HPPK_ECOLI) |
6-HYDROXYMETHYLPTERIN-DIPHOSPHATE |
HH2 |
|
0.41 |
SHOW |
30 | 6ADU |
12-epi-hapalindole U synthase | Fischerella |
V5TER4 (V5TER4_9CYAN) |
(3~{Z})-3-(1-methylpyrrolidin-2-ylidene)indole |
9UL |
|
0.41 |
SHOW |